Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991393 · ClinicalTrials.gov registry record
Sinus Augmentation With Dental Implant
A clinical trial, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- 23
- Enrollment target
NCT00991393: Clinical Trial study, sponsored by Medtronic Spinal and Biologics.
NCT00991393 is a clinical trial that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991393 was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this research study is to shorten the treatment time course for patients who are scheduled for surgery to have a sinus lift and dental implant(s) placed into the upper front part of their mouth, and need to have more bone in their jaws and a thicker sinus floor to support the implant.
Interventions
- DEVICE INFUSE® Bone Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-01 |
Why NCT00991393 stopped before completion
NCT00991393 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which INFUSE® Bone Graft is the first listed.
NCT00991393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00991393 about?
NCT00991393 is a clinical study titled "Sinus Augmentation With Dental Implant". The purpose of this research study is to shorten the treatment time course for patients who are scheduled for surgery to have a sinus lift and dental implant(s) placed into the upper front part of their mouth, and need to have more bone in their jaws and a thicker sinus floor to support the implant.
What is the current status of trial NCT00991393?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2009-10. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00991393?
The interventions under investigation include: INFUSE® Bone Graft (DEVICE).
Who is sponsoring clinical trial NCT00991393?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia